Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-027772
Filing Date
2025-03-25
Accepted
2025-03-25 16:06:17
Documents
1
Period of Report
2025-03-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2510055-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2510055-3_4seq1.xml 4 4135
  Complete submission text file 0001104659-25-027772.txt   5691
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142
Business Address
Harshbarger Benjamin (Reporting) CIK: 0001653133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 25768308